Literature DB >> 646851

Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.

L Lundholm, L Jacobsson, R Brattsand, O Magnusson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 646851     DOI： 10.1016/0021-9150(78)90010-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  3 in total

1.  Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.

Authors:  Martina Lukasova; Camille Malaval; Andreas Gille; Jukka Kero; Stefan Offermanns
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

2.  Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.

Authors:  Alison M Strack; Ester Carballo-Jane; Sheng-Ping Wang; Jiyan Xue; Xiaoli Ping; Lesley Ann McNamara; Anil Thankappan; Olga Price; Michael Wolff; T J Wu; Douglas Kawka; Michele Mariano; Charlotte Burton; Ching H Chang; Jing Chen; John Menke; Silvi Luell; Emanuel I Zycband; Xinchun Tong; Richard Raubertas; Carl P Sparrow; Brian Hubbard; John Woods; Gary O'Neill; M Gerard Waters; Ayesha Sitlani
Journal:  J Lipid Res       Date:  2012-10-28       Impact factor: 5.922

Review 3.  Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

Authors:  Noemi Rotllan; Mercedes Camacho; Mireia Tondo; Elena M G Diarte-Añazco; Marina Canyelles; Karen Alejandra Méndez-Lara; Sonia Benitez; Núria Alonso; Didac Mauricio; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.